Literature DB >> 11119582

Mutagenic analysis of the 5' arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity.

M B Leahy1, D C Pritlove, L L Poon, G G Brownlee.   

Abstract

Short synthetic influenza virus-like RNAs derived from influenza virus promoter sequences were examined for their ability to stimulate the endonuclease activity of recombinant influenza virus polymerase complexes in vitro, an activity that is required for the cap-snatching activity of primers from host pre-mRNA. An extensive set of point mutants of the 5' arm of the influenza A virus viral RNA (vRNA) was constructed to determine the cis-acting elements which influenced endonuclease activity. Activity was found to be dependent on three features of the conserved vRNA termini: (i) the presence of the 5' hairpin loop structure, (ii) the identity of residues at positions 5 and 10 bases from the 5' terminus, and (iii) the presence of base pair interactions between the 5' and 3' segment ends. Further experiments discounted a role for the vRNA U track in endonuclease activation. This study represents the first mutagenic analysis of the influenza virus promoter with regard to endonuclease activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119582      PMCID: PMC113906          DOI: 10.1128/JVI.75.1.134-142.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  RNA and DNA hydrolysis are catalyzed by the influenza virus endonuclease.

Authors:  K Klumpp; L Doan; N A Roberts; B Handa
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

2.  Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template.

Authors:  L L Poon; D C Pritlove; E Fodor; G G Brownlee
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Metal ion catalysis of RNA cleavage by the influenza virus endonuclease.

Authors:  L Doan; B Handa; N A Roberts; K Klumpp
Journal:  Biochemistry       Date:  1999-04-27       Impact factor: 3.162

4.  A hairpin loop at the 5' end of influenza A virus virion RNA is required for synthesis of poly(A)+ mRNA in vitro.

Authors:  D C Pritlove; L L Poon; L J Devenish; M B Leahy; G G Brownlee
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  Rescue of synthetic RNAs into thogoto and influenza A virus particles using core proteins purified from Thogoto virus.

Authors:  P Gómez-Puertas; M B Leahy; P A Nuttall; A Portela
Journal:  Virus Res       Date:  2000-03       Impact factor: 3.303

6.  The genes of influenza virus.

Authors:  P Palese
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

7.  Nonviral oligonucleotides at the 5' terminus of cytoplasmic influenza viral mRNA deduced from cloned complete genomic sequences.

Authors:  R Dhar; R M Chanock; C J Lai
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

8.  5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus.

Authors:  J S Robertson
Journal:  Nucleic Acids Res       Date:  1979-08-24       Impact factor: 16.971

9.  Influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme.

Authors:  L Shi; D F Summers; Q Peng; J M Galarz
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

10.  The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity.

Authors:  U Desselberger; V R Racaniello; J J Zazra; P Palese
Journal:  Gene       Date:  1980-02       Impact factor: 3.688

View more
  22 in total

1.  Differential activation of influenza A virus endonuclease activity is dependent on multiple sequence differences between the virion RNA and cRNA promoters.

Authors:  Michael B Leahy; Giuseppe Zecchin; George G Brownlee
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Hairpin loop structure in the 3' arm of the influenza A virus virion RNA promoter is required for endonuclease activity.

Authors:  M B Leahy; H C Dobbyn; G G Brownlee
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Activation of influenza virus RNA polymerase by the 5' and 3' terminal duplex of genomic RNA.

Authors:  M-T Michael Lee; Klaus Klumpp; Paul Digard; Laurence Tiley
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

4.  NF-kappaB signaling differentially regulates influenza virus RNA synthesis.

Authors:  Naveen Kumar; Zhong-Tao Xin; Yuhong Liang; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

5.  Structure of influenza A polymerase bound to the viral RNA promoter.

Authors:  Alexander Pflug; Delphine Guilligay; Stefan Reich; Stephen Cusack
Journal:  Nature       Date:  2014-11-19       Impact factor: 49.962

6.  Recombinant influenza A viruses with enhanced levels of PB1 and PA viral protein expression.

Authors:  Alan Belicha-Villanueva; Juan R Rodriguez-Madoz; Jad Maamary; Alina Baum; Dabeiba Bernal-Rubio; Maria Minguito de la Escalera; Ana Fernandez-Sesma; Adolfo García-Sastre
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

7.  Mutational analyses of packaging signals in influenza virus PA, PB1, and PB2 genomic RNA segments.

Authors:  Yuhong Liang; Taoying Huang; Hinh Ly; Tristram G Parslow; Yuying Liang
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

8.  Bunyamwera bunyavirus RNA synthesis requires cooperation of 3'- and 5'-terminal sequences.

Authors:  John N Barr; Gail W Wertz
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  The RNA polymerase of influenza a virus is stabilized by interaction with its viral RNA promoter.

Authors:  George G Brownlee; Jane L Sharps
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Mutational analysis of the Uukuniemi virus (Bunyaviridae family) promoter reveals two elements of functional importance.

Authors:  Ramon Flick; Fredrik Elgh; Ralf F Pettersson
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.